🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
15.62
-0.16 (-1.01%)
At close: Nov 20, 2026, 4:00 PM EST
15.50
-0.12 (-0.77%)
After-hours: Nov 20, 2026, 7:39 PM EST

Arcus Biosciences Statistics

Total Valuation

RCUS has a market cap or net worth of $2.25 billion. The enterprise value is $1.80 billion.

Market Cap2.25B
Enterprise Value 1.80B

Important Dates

The last earnings date was Wednesday, November 4, 2026, after market close.

Earnings Date Nov 4, 2026
Ex-Dividend Date n/a

Share Statistics

RCUS has 143.99 million shares outstanding. The number of shares has increased by 23.52% in one year.

Current Share Class 143.99M
Shares Outstanding 143.99M
Shares Change (YoY) +23.52%
Shares Change (QoQ) +1.03%
Owned by Insiders (%) 3.19%
Owned by Institutions (%) 64.86%
Float 107.19M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 22.49
Forward PS 100.11
PB Ratio 5.57
P/TBV Ratio 6.28
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 17.96
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 3.34, with a Debt / Equity ratio of 0.67.

Current Ratio 3.34
Quick Ratio 3.28
Debt / Equity 0.67
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -43.18

Financial Efficiency

Return on equity (ROE) is -114.11% and return on invested capital (ROIC) is -69.96%.

Return on Equity (ROE) -114.11%
Return on Assets (ROA) -50.56%
Return on Invested Capital (ROIC) -69.96%
Return on Capital Employed (ROCE) -76.74%
Weighted Average Cost of Capital (WACC) 9.59%
Revenue Per Employee $166,389
Profits Per Employee -$753,744
Employee Count601
Asset Turnover 0.11
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -22.75% in the last 52 weeks. The beta is 1.09, so RCUS's price volatility has been similar to the market average.

Beta (5Y) 1.09
52-Week Price Change -22.75%
50-Day Moving Average 21.47
200-Day Moving Average 24.34
Relative Strength Index (RSI) 28.58
Average Volume (20 Days) 1,601,938

Short Selling Information

The latest short interest is 13.18 million, so 9.15% of the outstanding shares have been sold short.

Short Interest 13.18M
Short Previous Month 13.11M
Short % of Shares Out 9.15%
Short % of Float 12.29%
Short Ratio (days to cover) 5.40

Income Statement

In the last 12 months, RCUS had revenue of $100.00 million and -$453.00 million in losses. Loss per share was -$3.64.

Revenue100.00M
Gross Profit -373.00M
Operating Income -475.00M
Pretax Income -453.00M
Net Income -453.00M
EBITDA -465.00M
EBIT -475.00M
Loss Per Share -$3.64
Full Income Statement

Balance Sheet

The company has $694.00 million in cash and investments and $241.00 million in debt, with a net cash position of $453.00 million or $3.15 per share.

Cash & Investments 694.00M
Total Debt 241.00M
Net Cash 453.00M
Net Cash Per Share $3.15
Equity (Book Value) 358.00M
Book Value Per Share 2.81
Working Capital 465.00M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$465.00 million and capital expenditures -$1.00 million, giving a free cash flow of -$466.00 million.

Operating Cash Flow -465.00M
Capital Expenditures -1.00M
Depreciation & Amortization 10.00M
Net Borrowing n/a
Free Cash Flow -466.00M
FCF Per Share -$3.24
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin -475.00%
Pretax Margin -453.00%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

RCUS does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -23.52%
Shareholder Yield -23.52%
Earnings Yield -23.32%
FCF Yield -20.72%

Analyst Forecast

The average price target for RCUS is $40.92, which is 161.97% higher than the current price. The consensus rating is "Strong Buy".

Price Target $40.92
Price Target Difference 161.97%
Analyst Consensus Strong Buy
Analyst Count 15
Revenue Growth Forecast (3Y) -31.76%
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

RCUS has an Altman Z-Score of -0.4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score -0.4
Piotroski F-Score n/a